▶ 調査レポート

自家ワクチンの世界市場

• 英文タイトル:Global Market Study on Autogenous Vaccines: Increasing Funding for Animal Disease Eradication and Immunization Propelling Growth

Persistence Market Researchが調査・発行した産業分析レポートです。自家ワクチンの世界市場 / Global Market Study on Autogenous Vaccines: Increasing Funding for Animal Disease Eradication and Immunization Propelling Growth / PMR20MY090資料のイメージです。• レポートコード:PMR20MY090
• 出版社/出版日:Persistence Market Research / 2020年1月24日
• レポート形態:英文、PDF、176ページ
• 納品方法:Eメール
• 産業分類:生命科学&トランスフォーメーショナルヘルス
• 販売価格(消費税別)
  Individual User(1名用)¥509,600 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥790,400 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,102,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の自家ワクチン市場について調査・分析し、エグゼクティブサマリー、市場概要、市場動向、市場状況、市場需要分析及び予測、市場背景、北米、中南米、ヨーロッパ、南アジア市場分析などを含め、以下の構成でお届け致します。
・世界の自家ワクチン市場:エグゼクティブサマリー
・世界の自家ワクチン市場:概要
・世界の自家ワクチン市場:動向
・世界の自家ワクチン市場:状況
・世界の自家ワクチン市場:需要分析及び予測
・世界の自家ワクチン市場:背景
・北米の自家ワクチン市場:分析及び予測
・中南米の自家ワクチン市場:分析及び予測
・ヨーロッパ自家ワクチン市場:分析及び予測
・南アジア自家ワクチン市場:分析及び予測

Autogenous Vaccines Market: Scope of the Report

Persistence Market Research (PMR) recently published a study on the global autogenous vaccines market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the autogenous vaccines market structure. The market study presents exclusive information about how the autogenous vaccines market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes pricing analysis by region and by product type, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. The other information contains volume analysis, which includes year wise growth of autogenous vaccines during the forecast period. This information can help readers understand the quantitative growth prospects of the autogenous vaccines market during the forecast period.

The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, industry experts can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the autogenous vaccines market. Furthermore, small businesses and new entrants in the autogenous vaccines market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR’s Autogenous Vaccines Market Report

Which regions will continue to remain the most profitable regional markets for autogenous vaccines market players?
Which factors will induce a change in the demand for autogenous vaccines during the assessment period?
What are the different opportunities available for emerging players in the autogenous vaccines market?
How are supply-side and demand-side drivers impacting the autogenous vaccines market?
How will changing trends impact the autogenous vaccines market?
How can market players capture the low-hanging opportunities in the autogenous vaccines market in developed regions?
Which companies are leading the autogenous vaccines market?
What are the winning strategies of stakeholders in the autogenous vaccines market to upscale their position in this landscape?
Autogenous Vaccines Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the autogenous vaccines market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analyst ensure accuracy and reliability of conclusions.

Secondary resources referred to analyst during the production of the autogenous vaccines market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the autogenous vaccines market, and makes PMR’s projection on the growth prospects of the autogenous vaccines market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Market Context

4.1. Regulatory Scenario

4.2. Parent Market Analysis

5. Global Autogenous Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.2. Forecast Factors – Relevance & Impact

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Global Autogenous Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Strain Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) & Volume (Mn Units) Analysis By Strain Type, 2014 – 2018

7.3. Current and Future Market Size (US$ Mn) & Volume (Mn Units) Analysis and Forecast By Strain Type, 2019 – 2029

7.3.1. Bacterial Strain

7.3.2. Virus Strain

7.4. Market Attractiveness Analysis By Strain Type

8. Global Autogenous Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by End User

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029

8.3.1. Veterinary Clinics

8.3.2. Veterinary Hospitals

8.3.3. Veterinary Research Institutes

8.4. Market Attractiveness Analysis By End User

9. Global Autogenous Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. East Asia

9.3.5. South Asia

9.3.6. Oceania

9.3.7. Middle East & Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Strain Type

10.3.3. By End User

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Strain Type

10.4.3. By End User

11. Latin America Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Rest of Latin America

11.3.2. By Strain Type

11.3.3. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Strain Type

11.4.3. By End User

12. Europe Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. BENELUX

12.3.1.7. Russia

12.3.1.8. Rest of Europe

12.3.2. By Strain Type

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Strain Type

12.4.3. By End User

13. South Asia Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. India

13.3.1.2. Thailand

13.3.1.3. Indonesia

13.3.1.4. Malaysia

13.3.1.5. Rest of South Asia

13.3.2. By Strain Type

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Strain Type

13.4.3. By End User

14. East Asia Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Country

14.3.1.1. China

14.3.1.2. Japan

14.3.1.3. South Korea

14.3.2. By Strain Type

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Strain Type

14.4.3. By End User

15. Oceania Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Country

15.3.1.1. Australia

15.3.1.2. New Zealand

15.3.2. By Strain Type

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Strain Type

15.4.3. By End User

16. Middle East and Africa Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

16.3.1. By Country

16.3.1.1. GCC Countries

16.3.1.2. Turkey

16.3.1.3. Northern Africa

16.3.1.4. South Africa

16.3.1.5. Rest of Middle East and Africa

16.3.2. By Strain Type

16.3.3. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Strain Type

16.4.3. By End User

17. Emerging Countries Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.1.1. Market Value Proportion Analysis, By Key Countries

17.1.2. Global Vs. Country Growth Comparison

17.2. China Autogenous Vaccines Market Analysis

17.2.1. Introduction

17.2.2. Market Value Proportion Analysis by Market Taxonomy

17.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

17.2.3.1. By Strain Type

17.2.3.2. By End User

17.3. India Autogenous Vaccines Market Analysis

17.3.1. Introduction

17.3.2. Market Value Proportion Analysis by Market Taxonomy

17.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

17.3.3.1. By Strain Type

17.3.3.2. By End User

17.4. Brazil Autogenous Vaccines Market Analysis

17.4.1. Introduction

17.4.2. Market Value Proportion Analysis by Market Taxonomy

17.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

17.4.3.1. By Strain Type

17.4.3.2. By End User

18. Market Structure Analysis

19. Competition Analysis

19.1. Competition Dashboard

19.2. Competition Deep Dive

19.2.1. Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)

19.2.1.1. Overview

19.2.1.2. Product Portfolio

19.2.1.3. Profitability by Market Segments (Product/Channel/Region)

19.2.1.4. Sales Footprint

19.2.1.5. Strategy Overview

19.2.1.5.1. Marketing Strategy

19.2.1.5.2. Product Strategy

19.2.1.5.3. Channel Strategy

19.2.2. Elanco Animal Health

19.2.2.1. Overview

19.2.2.2. Product Portfolio

19.2.2.3. Profitability by Market Segments (Product/Channel/Region)

19.2.2.4. Sales Footprint

19.2.2.5. Strategy Overview

19.2.2.5.1. Marketing Strategy

19.2.2.5.2. Product Strategy

19.2.2.5.3. Channel Strategy

19.2.3. Ceva (Ceva Biovac)

19.2.3.1. Overview

19.2.3.2. Product Portfolio

19.2.3.3. Profitability by Market Segments (Product/Channel/Region)

19.2.3.4. Sales Footprint

19.2.3.5. Strategy Overview

19.2.3.5.1. Marketing Strategy

19.2.3.5.2. Product Strategy

19.2.3.5.3. Channel Strategy

19.2.4. Cambridge Technologies

19.2.4.1. Overview

19.2.4.2. Product Portfolio

19.2.4.3. Profitability by Market Segments (Product/Channel/Region)

19.2.4.4. Sales Footprint

19.2.4.5. Strategy Overview

19.2.4.5.1. Marketing Strategy

19.2.4.5.2. Product Strategy

19.2.4.5.3. Channel Strategy

19.2.5. Hygieia Biological Laboratories

19.2.5.1. Overview

19.2.5.2. Product Portfolio

19.2.5.3. Profitability by Market Segments (Product/Channel/Region)

19.2.5.4. Sales Footprint

19.2.5.5. Strategy Overview

19.2.5.5.1. Marketing Strategy

19.2.5.5.2. Product Strategy

19.2.5.5.3. Channel Strategy

19.2.6. Dyntec s. r. o

19.2.6.1. Overview

19.2.6.2. Product Portfolio

19.2.6.3. Profitability by Market Segments (Product/Channel/Region)

19.2.6.4. Sales Footprint

19.2.6.5. Strategy Overview

19.2.6.5.1. Marketing Strategy

19.2.6.5.2. Product Strategy

19.2.6.5.3. Channel Strategy

19.2.7. Phibro Animal Health Corporation

19.2.7.1. Overview

19.2.7.2. Product Portfolio

19.2.7.3. Profitability by Market Segments (Product/Channel/Region)

19.2.7.4. Sales Footprint

19.2.7.5. Strategy Overview

19.2.7.5.1. Marketing Strategy

19.2.7.5.2. Product Strategy

19.2.7.5.3. Channel Strategy

19.2.8. Huvepharma, Inc.

19.2.8.1. Overview

19.2.8.2. Product Portfolio

19.2.8.3. Profitability by Market Segments (Product/Channel/Region)

19.2.8.4. Sales Footprint

19.2.8.5. Strategy Overview

19.2.8.5.1. Marketing Strategy

19.2.8.5.2. Product Strategy

19.2.8.5.3. Channel Strategy

19.2.9. Deltamune

19.2.9.1. Overview

19.2.9.2. Product Portfolio

19.2.9.3. Profitability by Market Segments (Product/Channel/Region)

19.2.9.4. Sales Footprint

19.2.9.5. Strategy Overview

19.2.9.5.1. Marketing Strategy

19.2.9.5.2. Product Strategy

19.2.9.5.3. Channel Strategy

19.2.10. AniCon Labor GmbH

19.2.10.1. Overview

19.2.10.2. Product Portfolio

19.2.10.3. Profitability by Market Segments (Product/Channel/Region)

19.2.10.4. Sales Footprint

19.2.10.5. Strategy Overview

19.2.10.5.1. Marketing Strategy

19.2.10.5.2. Product Strategy

19.2.10.5.3. Channel Strategy

19.2.11. ACE Laboratory Services (Apiam Animal Health)

19.2.11.1. Overview

19.2.11.2. Product Portfolio

19.2.11.3. Profitability by Market Segments (Product/Channel/Region)

19.2.11.4. Sales Footprint

19.2.11.5. Strategy Overview

19.2.11.5.1. Marketing Strategy

19.2.11.5.2. Product Strategy

19.2.11.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

List of Table

Table 01: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 02: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 03: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 04: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 05: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 06: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 07: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 08: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 09: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 10: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 11: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 12: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 13: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 15: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 16: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 17: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 18: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 19: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 20: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 21: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 22: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 23: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 24: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 25: China Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 26: China Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 27: India Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 28: India Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 29: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type

Table 30: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User